Comparison of Direct Oral Anticoagulants and Vitamin K Antagonists for Left Ventricular Thrombus: A Global Retrospective Study — Zhihong Yao (2024) | RDL Network
DOACs demonstrated better safety and efficacy outcomes when compared with VKAs in left ventricular thrombus treatment, with or without recent acute coronary syndrome.
David Seiffge, Maurizio Paciaroni, Duncan Wilson, Masatoshi Koga, Kosmas Macha, Manuel Cappellari, Sabine Schaedelin, Clare Shakeshaft, Masahito Takagi, Georgios Tsivgoulis, Bruno Bonetti, Bernd Kallmünzer, Shoji Arihiro, Andrea Alberti, Alexandros A. Polymeris, Gareth Ambler, Sohei Yoshimura, Michele Venti, Leo H. Bonati, Keith W. Muir, Hiroshi Yamagami, Sebastian Thilemann, Riccardo Altavilla, Nils Peters, Manabu Inoue, Tobias Bobinger, Giancarlo Agnelli, Martin M. Brown, Shoichiro Sato, Monica Acciarresi, Hans Rolf Jäger, Paolo Bovi, Stefan Schwab, Philippe Lyrer, Valeria Caso, Ḱazunori Toyoda, David J. Werring, Stefan T. Engelter, Gian Marco De Marchis
Behnood Bikdeli, Farbod Zahedi Tajrishi, Parham Sadeghipour, Azita H. Talasaz, John Fanikos, Giuseppe Lippi, Deborah Siegal, John W. Eikelboom, Manuel Monréal, David Jiménez, Jean M. Connors, Walter Ageno, Geoffrey D. Barnes, Gregory Piazza, Dominick J. Angiolillo, Sahil A. Parikh, Ajay J. Kirtane, Renato D. Lópes, Deepak L. Bhatt, Jeffrey I. Weitz, Roxana Mehran, Harlan M. Krumholz, Samuel Z. Goldhaber, Professor Gregory Lip
Discussion(0)
No comments yet. Be the first to comment.